Join to View Full Profile
100 E Idaho StBoise, ID 83712
Phone+1 208-381-2711
Fax+1 208-381-4025
Dr. Montgomery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Montgomery is a medical oncologist and hematologist based in Boise, ID since 1991. He completed his medical education at the University of Washington School of Medicine and completed residency in internal medicine, and fellowships in hematology and medical oncology at the Mayo Clinic College of Medicine and Science. Dr. Montgomery has co-authored several publications. He was has been a Fellow of the American College of Physicians since 1997.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1988 - 1991- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1985 - 1988
University of Washington School of MedicineClass of 1985
Certifications & Licensure
ID State Medical License 1991 - 2027
OR State Medical License 1991 - 2027
MN State Medical License 1986 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Publications & Presentations
PubMed
- 1 citationsOverlooked barriers to implementation of geriatric assessment.Banu E Symington, Paul G Montgomery
CA. 2024-08-29 - 53 citationsA phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymp...Marek Trnĕný, Gregor Verhoef, Martin J. S. Dyer, Dina Ben Yehuda, Caterina Patti
Haematologica. 2018-05-10 - 27 citationsLong‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphomaPeter Martin, Zhengming Chen, Bruce D. Cheson, Katherine Sue Robinson, Michael D. Williams
British Journal of Haematology. 2017-07-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
